About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

NCT05115006·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bristol-Myers Squibb

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Self-reported medical diagnosis of stage II or stage III melanoma
Have been resected (had surgery) for their melanoma within 12 months prior to study participation

You may not be if

Self-reported stage IIa
Self-reported recurrence of melanoma after surgery

The record

StatusCompleted

PhaseNo phase

Taking part294

StartedJan 2021

UpdatedJun 30, 2022

Conditions

Where1

Local Institution
Melbourne, Victoria, Australia